Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-24

FDA Approved: CLOBAZAM — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CLOBAZAM filed by Bionpharma Inc., confirming an additional approval for this clobazam product. The snippet does…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

SUPPL AP for CLOBAZAM (CLOBAZAM)